PubMed

Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications.

Franchini M, Capra F, Targher G, Montagnana M, Lippi G.

Thromb J. 2007 Sep 25;5:14.PMID: 17894864 [PubMed - in process]Related articlesFree article

ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?

Jenkins PV, O'Donnell JS.

Transfusion. 2006 Oct;46(10):1836-44. Review.PMID: 17002642 [PubMed - indexed for MEDLINE]Related articles

Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.

Lethagen S, Hillarp A, Ekholm C, Mattson E, Halldén C, Friberg B.

Thromb Haemost. 2008 Jun;99(6):1013-8.PMID: 18521502 [PubMed - indexed for MEDLINE]Related articles

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A.

Blood. 2008 Apr 1;111(7):3540-5. Epub 2008 Feb 1.PMID: 18245665 [PubMed - indexed for MEDLINE]Related articlesFree article

C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels.

Davies JA, Collins PW, Hathaway LS, Bowen DJ.

Acta Haematol. 2009;121(2-3):98-101. Epub 2009 Jun 8. Review.PMID: 19506354 [PubMed - indexed for MEDLINE]Related articles

Genetics of type 1 von Willebrand disease.

Goodeve A.

Curr Opin Hematol. 2007 Sep;14(5):444-9. Review. Erratum in: Curr Opin Hematol. 2008 Mar;15(2):154. PMID: 17934350 [PubMed - indexed for MEDLINE]Related articles

Type 1 von Willebrand disease: application of emerging data to clinical practice.

Collins PW, Cumming AM, Goodeve AC, Lillicrap D.

Haemophilia. 2008 Jul;14(4):685-96. Epub 2008 May 23. Review.PMID: 18510569 [PubMed - indexed for MEDLINE]Related articles

Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.

Castaman G, Tosetto A, Rodeghiero F.

J Thromb Haemost. 2009 Jul;7 Suppl 1:71-4. Review.PMID: 19630772 [PubMed - indexed for MEDLINE]Related articles

Alpha 2A adrenergic receptor polymorphism is associated with plasma von Willebrand factor levels in a general population.

Yabe M, Matsubara Y, Takahashi S, Ishihara H, Shibano T, Watanabe G, Murata M, Ikeda Y.

Blood Coagul Fibrinolysis. 2008 Jul;19(5):395-9.PMID: 18600088 [PubMed - indexed for MEDLINE]Related articles

Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions.

Daidone V, Cattini MG, Pontara E, Sartorello F, Gallinaro L, Marotti A, Scaroni C, Pagnan A, Casonato A.

Thromb Haemost. 2009 Feb;101(2):298-304.PMID: 19190813 [PubMed - indexed for MEDLINE]Related articles

von Willebrand factor: evidence for variable clearance in vivo according to Y/C1584 phenotype and ABO blood group.

Davies JA, Collins PW, Hathaway LS, Bowen DJ.

J Thromb Haemost. 2008 Jan;6(1):97-103. Epub 2007 Oct 22.PMID: 17949477 [PubMed - indexed for MEDLINE]Related articles

An inquiry into the relationship between ABO blood group and thrombotic thrombocytopenic purpura.

Staropoli JF, Stowell CP, Tuncer HH, Marques MB.

Vox Sang. 2009 Feb 10. [Epub ahead of print]PMID: 19215624 [PubMed - as supplied by publisher]Related articles

Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease.

Favaloro EJ, Thom J, Patterson D, Just S, Baccala M, Dixon T, Meiring M, Koutts J, Rowell J, Baker R.

Blood Coagul Fibrinolysis. 2009 Sep;20(6):475-83.PMID: 19584715 [PubMed - indexed for MEDLINE]Related articles

Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.

Shihong I, Morris D, Konkle BA.

Haemophilia. 2009 Jan;15(1):131-4. Epub 2008 Oct 23.PMID: 18976254 [PubMed - indexed for MEDLINE]Related articles

Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.

Terraube V, O'Donnell JS, Jenkins PV.

Haemophilia. 2009 Apr 16. [Epub ahead of print]PMID: 19473409 [PubMed - as supplied by publisher]Related articles

The effect of ABO blood group on von Willebrand response to exercise.

Ribeiro JL, Salton GD, Bandinelli E, Oliveira AR, Roisenberg I.

Clin Appl Thromb Hemost. 2008 Oct;14(4):454-8. Epub 2007 Dec 26.PMID: 18160595 [PubMed - indexed for MEDLINE]Related articles

Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.

Molvarec A, Rigó J Jr, Bõze T, Derzsy Z, Cervenak L, Makó V, Gombos T, Udvardy ML, Hársfalvi J, Prohászka Z.

Thromb Haemost. 2009 Feb;101(2):305-11.PMID: 19190814 [PubMed - indexed for MEDLINE]Related articles

Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.

Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA.

Blood Coagul Fibrinolysis. 2009 Mar;20(2):89-100. Review.PMID: 19786936 [PubMed - indexed for MEDLINE]Related articles

Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome.

Casonato A, Daidone V, Sartorello F, Albiger N, Romualdi C, Mantero F, Pagnan A, Scaroni C.

Br J Haematol. 2008 Jan;140(2):230-5.PMID: 18173757 [PubMed - indexed for MEDLINE]Related articles

Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.

Millar CM, Riddell AF, Brown SA, Starke R, Mackie I, Bowen DJ, Jenkins PV, van Mourik JA.

Thromb Haemost. 2008 May;99(5):916-24.PMID: 18449422 [PubMed - indexed for MEDLINE]Related articles